口服、肌肉注射和静脉注射后人体血浆中丙氧芬的浓度。 - Suppr | 超能文献

文献检索
文档翻译
深度研究
学术资讯

Zotero 插件

邀请有礼
套餐&价格
历史记录

应用&插件

Zotero 插件浏览器插件 Mac 客户端 Windows 客户端微信小程序

定价

高级版会员购买积分包购买API积分包

服务

文献检索文档翻译深度研究 API 文档 MCP 服务

关于我们

关于 Suppr 公司介绍联系我们用户协议隐私条款

关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究

粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

口服、肌肉注射和静脉注射后人体血浆中丙氧芬的浓度。 - Suppr | 超能文献

Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.

作者信息

Wolen R L, Gruber C M, Kiplinger G F, Scholz N E

出版信息

Toxicol Appl Pharmacol. 1971 Jul;19(3):480-92. doi: 10.1016/0041-008x(71)90006-8.

DOI:10.1016/0041-008x(71)90006-8

Abstract

摘要

相似文献

1

Concentration of propoxyphene in human plasma following oral, intramuscular, and intravenous administration.口服、肌肉注射和静脉注射后人体血浆中丙氧芬的浓度。

Toxicol Appl Pharmacol. 1971 Jul;19(3):480-92. doi: 10.1016/0041-008x(71)90006-8.

2

Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case II--equipotent doses.利用混合主成分方差分析技术评估丙氧芬的血浆浓度。案例二——等效剂量。

Toxicol Appl Pharmacol. 1971 Jul;19(3):563-71. doi: 10.1016/0041-008x(71)90016-0.

3

Evaluation of plasma concentrations of propoxyphene utilizing a hybrid principal component-analysis of variance technique. Case 1--equimolar doses.利用混合主成分方差分析技术评估丙氧芬的血浆浓度。病例1——等摩尔剂量。

Toxicol Appl Pharmacol. 1971 Jul;19(3):554-62. doi: 10.1016/0041-008x(71)90015-9.

4

Concentration of propoxyphene in human plasma following repeated oral doses.多次口服给药后人体内血浆中丙氧芬的浓度。

Toxicol Appl Pharmacol. 1971 Jul;19(3):493-7. doi: 10.1016/0041-008x(71)90007-x.

5

d-Propoxyphene kinetics after single oral and intravenous doses in man.

Clin Pharmacol Ther. 1979 Oct;26(4):473-82. doi: 10.1002/cpt1979264473.

6

Influence of first-pass effect on the systemic availability of propoxyphene.

J Clin Pharmacol New Drugs. 1972 Nov-Dec;12(11):449-52. doi: 10.1002/j.1552-4604.1972.tb00245.x.

7

Plasma concentrations of propoxyphene in man. I. Following oral administration of the drug in solution and capsule forms.人体内丙氧芬的血浆浓度。I. 口服溶液剂和胶囊剂后的情况。

Int Z Klin Pharmakol Ther Toxikol. 1972 Feb;5(4):371-80.

8

A study of propoxyphene and salicylate concentrations in human plasma following the administration of propoxyphene napsylate and aspirin.萘磺酸右丙氧芬与阿司匹林联合给药后人体血浆中右丙氧芬和水杨酸盐浓度的研究。

Toxicol Appl Pharmacol. 1971 Jul;19(3):537-45. doi: 10.1016/0041-008x(71)90013-5.

9

Acute toxicity of propoxyphene salts.

Toxicol Appl Pharmacol. 1971 Jul;19(3):445-51. doi: 10.1016/0041-008x(71)90003-2.

10

Plasma concentrations of propoxyphene in man. II. Pharmacokinetics.人体内丙氧芬的血浆浓度。II. 药代动力学。

Int Z Klin Pharmakol Ther Toxikol. 1972 Feb;5(4):381-8.

引用本文的文献

1

Plasma concentration and disposition of buprenorphine after intravenous and intramuscular doses to baboons.

Eur J Drug Metab Pharmacokinet. 1980;5(4):233-9. doi: 10.1007/BF03189469.

2

D-propoxyphene kinetics in man: significance of a deep third compartment.D-丙氧芬在人体中的动力学：深部第三房室的意义。

Eur J Clin Pharmacol. 1984;26(6):749-52. doi: 10.1007/BF00541937.

3

Dextropropoxyphene overdosage. Pharmacological considerations and clinical management.右丙氧芬过量。药理学考量与临床处理

Drugs. 1983 Jul;26(1):70-9. doi: 10.2165/00003495-198326010-00004.

4

Problems associated with bioavailability and dosage regiment studies in man.与人体生物利用度和给药方案研究相关的问题。

J Pharmacokinet Biopharm. 1974 Aug;2(4):365-77. doi: 10.1007/BF01061408.

5

Dextropropoxyphene kinetics after single and repeated oral doses in man.右丙氧芬在人体单次及多次口服给药后的动力学

Eur J Clin Pharmacol. 1985;29(1):79-84. doi: 10.1007/BF00547373.

6

Dextropropoxyphene overdose. Epidemiology, clinical presentation and management.右旋丙氧芬过量。流行病学、临床表现及处理

Med Toxicol Adverse Drug Exp. 1987 Nov-Dec;2(6):430-44. doi: 10.1007/BF03259877.

7

Pharmacokinetics of dextropropoxyphene and nordextropropoxyphene in young and elderly volunteers after single and multiple dextropropoxyphene dosage.右丙氧芬和去甲右丙氧芬在年轻和老年志愿者单次及多次服用右丙氧芬后的药代动力学

Br J Clin Pharmacol. 1989 Oct;28(4):463-9. doi: 10.1111/j.1365-2125.1989.tb03527.x.

8

Enhancement of propoxyphene bioavailability by ethanol. Relation to psychomotor and cognitive function in healthy volunteers.

Eur J Clin Pharmacol. 1991;41(2):147-52. doi: 10.1007/BF00265908.

9

Clinical pharmacokinetics in infants and children.婴幼儿临床药代动力学

Clin Pharmacokinet. 1976;1(1):2-24. doi: 10.2165/00003088-197601010-00002.

10

Effect of route of administration and distribution on drug action.

J Pharmacokinet Biopharm. 1978 Dec;6(6):559-85. doi: 10.1007/BF01062110.